SEC Form 4 · accession 0001078274-19-000006
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven S Myers
Director
Period of report
Jan 8, 2019
Accepted (ET)
Jan 10, 2019 · 12:24 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jan 8, 2019 | A | 8,747 | $0.00 | A | 44,906 | D | |
| Common Stock | holding | — | — | — | 8,434 | I | By Steven S Myers IRA | |
| Common Stock | holding | — | — | — | 802 | I | By spouse | |
| Common Stock | holding | — | — | — | 1,954 | I | By Steven S Myers Revocable Trust dated 12/1/2000 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Represents 8,747 shares underlying restricted stock granted under the 2018 Equity Incentive Compensation Plan which were awarded on January 8, 2018 and which vested on January 8, 2019.